-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Downgrades Braskem to Neutral, Lowers Price Target to $3.8

Benzinga·09/26/2025 11:18:06
Listen to the news
UBS analyst Tasso Vasconcellos downgrades Braskem (NYSE: BAK) from Buy to Neutral and lowers the price target from $5.1 to $3.8.